Format

Send to

Choose Destination
Free Radic Biol Med. 2014 Apr;69:367-76. doi: 10.1016/j.freeradbiomed.2014.02.001. Epub 2014 Feb 7.

PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities.

Author information

1
College of Pharmacy & Medical Research Center, Chungbuk National University, Chungbuk 361-763, Republic of Korea.
2
Research Center for Cell Fate Control, College of Pharmacy, Sookmyung Women׳s University, Seoul 140-742, Republic of Korea.
3
Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 150-716, Republic of Korea.
4
College of Pharmacy & Medical Research Center, Chungbuk National University, Chungbuk 361-763, Republic of Korea. Electronic address: shan@cbnu.ac.kr.
5
College of Pharmacy & Medical Research Center, Chungbuk National University, Chungbuk 361-763, Republic of Korea. Electronic address: jinthong@chungbuk.ac.kr.

Abstract

PRDX6 is a bifunctional protein with both glutathione peroxidase (GPx) and calcium-independent phospholipase A2 (iPLA2) activities, which are concomitantly increased with the expression of PRDX6. PRDX6 promoted lung tumor growth in an in vivo allograft model. Herein, we further studied the vital roles in tumor progression of PRDX6 in lung cancer using nude mice bearing PRDX6-overexpressing lung cancer cells. Nude mice xenografted with PRDX6 showed increases in tumor size and weight compared to control mice. Histopathological and Western blotting examination demonstrated that expression of proliferating cell nuclear antigen, vascular endothelial growth factor, metalloproteinases 2 and 9, and cyclin-dependent kinases accompanied by increased iPLA2 and GPx activities were increased in the tumor tissues of PRDX6-overexpressing nude mice. In tumor tissues of PRDX6-overexpressing mice, the activation of mitogen-activated protein kinases and AP-1 DNA binding were also increased. The growth of lung cancer cell lines (A549 and NCI-H460) was enhanced by the increase in iPLA2 and GPx activities of PRDX6. In addition, mutant PRDX6 (C47S) attenuated PRDX6-mediated p38, ERK1/2, and AP-1 activities as well as its enzyme activities in the A549 and NCI-H460 lines. Furthermore, tumor growth and p38, ERK1/2, and AP-1 activities were also inhibited in nude mice bearing mutant PRDX6 (C47S) compared to PRDX6. Therefore, our findings indicate that PRDX6 promotes lung tumor growth via increased glutathione peroxidase and iPLA2 activities.

KEYWORDS:

AP-1; Free radicals; GPx; MAPK; PRDX6; iPLA2

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center